Citadel founder Ken Griffin warns that an environment where corporate success depends on currying favor with the White House is 'incredibly distasteful' and undermines fair competition, even as he acknowledges regulatory relief under the current administration.
Wall Street grapples with a pronounced sector rotation out of high-flying technology names, driving volatility across major indices. Amid the shift, analyst calls highlight potential value in energy, consumer discretionary, and select fintech stocks for February 4, 2026.
A recent 12% monthly uptick offers little solace to long-term investors in Dutch offshore foundation specialist Sif Holding, who have seen their holdings erode by more than half over five years. We examine the underlying fundamentals and market sentiment behind the prolonged downturn.
A delivery truck carrying workers veered off a mountain road in Bayawan City, Negros Oriental, plummeting into a 30-meter ravine and killing all nine on board. The tragedy renews focus on the country's persistently high rate of fatal road accidents linked to enforcement gaps and infrastructure failures.
A new Congressional Budget Office analysis reveals the staggering financial cost of deploying troops to American cities, raising profound questions about policy, politics, and civil-military boundaries.
Nasdaq is moving to slash the waiting period for new listings to join its flagship Nasdaq 100 index from three months to just 15 trading days, a strategic shift aimed at capturing the explosive market debuts of tech giants like SpaceX. The change highlights the intensifying competition among exchanges and index providers to adapt to a new era of blockbuster IPOs.
A wave of insider stock sales at Symbotic Inc. over the past year, including a multi-million dollar divestment, is prompting scrutiny from market watchers. While insider selling alone isn't a definitive sell signal, the absence of any insider buying during this period adds a layer of concern for shareholders evaluating the high-flying automation stock.
Facing intensifying competition for its blockbuster drugs Wegovy and Ozempic, Danish pharmaceutical leader Novo Nordisk has issued a sobering sales outlook for 2026, projecting its first annual decline since 2017 and triggering a sharp stock sell-off.
Amid a strong start for major indices, a look at three lesser-known companies where recent insider buying activity hints at underlying value and management confidence.
Financial experts warn that parking excess cash in a low-interest checking account is a common, costly mistake. We break down the optimal balance to strike between liquidity and lost yield.
In an exclusive interview, Palantir Technologies CTO Shyam Sankar argues that the U.S. must urgently leverage AI to supercharge worker productivity and counter China's economic strategy, citing a case where factory yields jumped 50%.
With major indices climbing on renewed economic optimism, investors are increasingly turning to dividend-paying stocks for a blend of income and stability. We analyze three financial sector contenders offering reliable yields and solid fundamentals for consideration in February 2026.
Recent volatility in Ipsos (ENXTPA:IPS) shares has investors questioning whether the stock's current price of €34.76 represents a buying opportunity, given a significant gap to some fair value estimates. We examine the data behind the valuation debate and the risks involved.
Shares of iFabric Corp. (TSE:IFA) have delivered a stunning 142% return to investors over the past three years, with a recent surge of 99% in just a quarter. The rally coincides with the company's journey to profitability, though analysts urge a closer look at the long-term trajectory and underlying fundamentals.
Bitwise's Matt Hougan argues the crypto market entered a bear phase at the start of 2025, a reality obscured by massive institutional buying. The debate now centers on when the thaw will begin.
UBS Group reported a 62% surge in underlying pre-tax profit for Q4 2025, driven by revenue momentum and cost discipline. The bank is nearing its post-merger targets but cautions that unlocking the final tranche of savings hinges on completing Swiss client migrations.
While XRP's price struggles within a bearish channel and exchange inflows spike, on-chain data reveals a nuanced story. Long-term investors appear to be absorbing supply from short-term sellers, potentially laying the groundwork for a rebound toward $1.70 if key support holds.
A coordinated wave of insider buying at Biote Corp. (NASDAQ:BTMD), totaling more than $1 million, signals strong executive confidence in the biotech firm's future, even as its stock price faces headwinds.
As Mayor Zohran Mamdani's rent freeze for stabilized units nears, data reveals a city where tenants are increasingly staying put. Economists warn this could deepen the housing shortage, creating a paradox where a policy meant to provide stability may inadvertently fuel fiercer competition and higher costs in the broader market.
Select Water Solutions (NYSE:WTTR) confirms a $0.07 per share dividend payment for February, yielding 2.3%. While the company demonstrates robust earnings growth, analysts flag its high payout ratio as a point of caution for income-focused investors.
